Issue 23, 2010

Preparation of a drug-eluting stent using a TiO2 film deposited by plasma enhanced chemical vapour deposition as a drug-combining matrix

Abstract

A TiO2 thin film was deposited onto a bare metal stent by the plasma enhanced chemical vapour deposition (PECVD) process and its potential as a drug-combining matrix was investigated. When deposited at a discharge power of 5 W, the film showed a highly smooth surface with a surface roughness of 9.4 nm, mechanical stability with good adhesion, and good blood compatibility. The film was surface-modified with water plasma to introduce hydroxyl groups on the TiO2 surface. Then, drugs could be chemically grafted to the modified surface through the formation of ester bonds between hydroxyl groups on the modified TiO2 film and carboxyl groups in the drugs. When heparin, α-lipoic acid, and abciximab were grafted onto the TiO2-deposited and surface-modified stents, the grafted amount was measured to be 106.1 μg for α-lipoic acid, 32.5 μg for abciximab, and 53.9 μg for heparin on average. In the in vitro drug-release test, heparin and abciximab were released continuously for 4 weeks but ALA showed a burst release within 6 days.

Graphical abstract: Preparation of a drug-eluting stent using a TiO2 film deposited by plasma enhanced chemical vapour deposition as a drug-combining matrix

Supplementary files

Article information

Article type
Paper
Submitted
03 Dec 2009
Accepted
17 Mar 2010
First published
30 Apr 2010

J. Mater. Chem., 2010,20, 4792-4801

Preparation of a drug-eluting stent using a TiO2 film deposited by plasma enhanced chemical vapour deposition as a drug-combining matrix

S. Song, Y. J. Park, J. Park, M. D. Cho, J. Kim, M. H. Jeong, Y. S. Kim and D. L. Cho, J. Mater. Chem., 2010, 20, 4792 DOI: 10.1039/B925409A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements